Overexpression of midkine in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters and their cell lines

Japanese Journal of Cancer Research

Volumn 91, Issue 10, 2000, Pages 979-986

  Tsutsumi, Masahiro ^a   Kadomatsu, Kenji ^b   Tsujiuchi, Toshifumi ^a   Sakitani, Hiroyuki ^a   Ikematsu, Shinya ^c   Kubozoe, Tadahiko ^a   Yoshimoto, Masatoshi ^a   Muramatsu, Takashi ^b   Sakuma, Sadatoshi ^c   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Meiji Cell Technology Center   (Japan)

Author keywords

4 HPR; Hamster; Midkine; Pancreatic duct carcinogenesis; TRA

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; FENRETINIDE; MESSENGER RNA; MIDKINE; RETINOIC ACID; RETINOID;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CONTROLLED STUDY; DRUG INDUCED CANCER; EMBRYO; EMBRYONAL TISSUE; FEMALE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SYRIAN HAMSTER;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CARCINOMA, PANCREATIC DUCTAL; CARRIER PROTEINS; CELL DIVISION; CELLS, CULTURED; CRICETINAE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FENRETINIDE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MESOCRICETUS; NITROSAMINES; PANCREATIC NEOPLASMS; RNA, MESSENGER; TRETINOIN;

EID: 0033762164     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00874.x     Document Type: Article

References (51)

1. Annual report to the nation on the status of cancer
2. Main causes of death in Japan
3. Cancer of the pancreas induced in the Syrian golden hamster
4. Selective induction of pancreatic ductular tumors by single dose of N-nitrosobis (2-oxopropyl)amine in Syrian golden hamsters
5. Current knowledge of pancreatic carcinogenesis in the hamster and its relation to the human disease
6. Rapid production of pancreatic carcinoma by initiation with N-nitrosobis(2-oxopropyl)amine and repeated augmentation pressure in hamsters
7. Cycles of repeated augmentation pressure in rapid production of pancreatic and cholangiocellular carcinomas in hamsters initiated with N-nitrosobis(2-oxopropyl)amine
8. Usefulness of a rapid production model for pancreatic carcinoma in male hamsters
9. New principle for the analysis of chemical carcinogenesis
10. Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine
11. Characterization of three cloned cell lines from a N-nitrosobis(2-hydroxypropyl) amine-induced transplantable hamster pancreatic ductal adenocarcinoma
12. Mechanistic analysis of pancreatic ductal carcinogenesis in hamsters
13. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR
14. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cell and in midgestation period of mouse embryogenesis
15. A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product
16. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in a spatially and temporally controlled manner during mouse embryogenesis
17. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis
18. Midkine (MK), a heparin-binding growth/ differentiation factor, is regulated by retinoic and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis
19. Purification of recombinant midkine and examination of its biological activities: Functional comparison of new heparin binding factors
20. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture
21. Midkine is a heat and acid stable polypeptide capable of enhancing plasminogen activator activity and neurite out-growth extension
22. A new family of heparin-binding growth/ differentiation factors: Increased midkine expression in Wilms' tumor and other human carcinomas
23. Increased midkine gene expression in human gastrointestinal cancers
24. Differential expression of pleiotrophin and midkine in advanced neuroblastomas
25. Midkine and pleiotrophin expression in normal and malignant breast tissue
26. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues
27. Increased expression of midkine during the progression of human astrocytomas
28. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers
29. Overexpression of midkine in lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats and its increase with progression
30. Midkine in the progression of rat N-nitroso-N-methylurea-induced mammary tumors
31. Laboratory methods: A method for isolation of intact, transcriptionally active ribonucleotic acid
32. Efficient extraction of RNA from mammalian tissue
33. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concominant increase in the levels of epidermal growth factor and transforming growth factor alpha
34. Production of transforming growth factor α in human pancreatic cancer cells: Evidence for a superagonist autocrine cycle
35. Insulin-like growth factor I overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles
36. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer
37. Expression of the met/hepatocyte growth factor receptor in human pancreatic cancer
38. Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases
39. A receptor-like protein-tyrosine phosphatase PTPζ/RPTPβ binds a heparin-binding growth factor midkine
40. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons
41. Midkine induces the transformation of NIH3T3 cells
42. Neointima formation in a restenosis model is suppressed in midkine-deficient mice
43. Midkine rescues Wilms tumor cells from cisplatin-induced apoptosis: Regulation of bcl-2 expression by midkine
44. Retinoids in cancer therapy
45. Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/ differentiation factor with neurotrophic activity
46. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells
47. Inhibitory effects of β-carotene, palm carotene, and green tea polyphenols on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters
48. Induction of angiogenesis during the transition from hyperplasia to neoplasia
49. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis
50. Prognostic significance of angiogenesis in human pancreatic cancer
51. Serum midkine levels are increased in patients with various types of carcinomas